← All Notable Labs, LTD filings

Notable Labs, LTD Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

OTC.Pink
NTBLQ
Notable Labs, LTD
Form 4: Notable Labs Director Acquires Shares Through Restricted Stock Grant
Director Tuomo Patsi acquired 65,247 ordinary shares of Notable Labs, Ltd. through a restricted stock grant on May 8, 2024.
OTC.Pink
NTBLQ
Notable Labs, LTD
Form 4: Notable Labs Executive Acquires 200,000 Stock Options
Joseph P. Wagner, Chief Scientific Officer of Notable Labs, Ltd., acquired 200,000 stock options on May 8, 2024, according to a recent SEC filing.
OTC.Pink
NTBLQ
Notable Labs, LTD
Form 4: Notable Labs Director Michele Galen Reports Acquisition of 40,247 Ordinary Shares
Director Michele Galen reports acquiring 40,247 ordinary shares of Notable Labs, Ltd. through a grant of restricted shares.
OTC.Pink
NTBLQ
Notable Labs, LTD
Form 4: Thomas Dubin Receives Restricted Shares in Notable Labs, Ltd.
Director Thomas Dubin acquired 40,247 restricted shares in Notable Labs, Ltd. on May 8, 2024, which vest in two equal annual installments.
OTC.Pink
NTBLQ
Notable Labs, LTD
Form 4: Notable Labs Director Thomas Graney Reports Acquisition of 40,247 Ordinary Shares
Director Thomas Graney reports acquiring 40,247 ordinary shares of Notable Labs, Ltd. through a grant of restricted shares.
OTC.Pink
NTBLQ
Notable Labs, LTD
Form 4: Peter Feinberg Acquires 40,247 Ordinary Shares of Notable Labs, Ltd.
Director Peter Feinberg acquired 40,247 ordinary shares of Notable Labs, Ltd. on May 8, 2024, through a grant of restricted shares.
OTC.Pink
NTBLQ
Notable Labs, LTD
Form 4: Notable Labs CEO Thomas Bock Receives Stock and Options Grant
Thomas Bock, CEO of Notable Labs, receives 400,000 ordinary shares and options for 150,000 shares.